- Antibodies
- Assay Kits
- Biology Cells
- Blogging
- cDNA
- Clia Kits
- Culture Cells
- Devices
- DNA
- DNA Testing
- Dual energy CT and research of the bone marrow edema: Comparison with MRI imaging.
- Elisa Kits
- Enzymes
- Equipments
- Exosomes
- Gels
- Isotypes
- Medium & Serums
- Panel
- Particles
- PCR
- Pcr Kits
- Peptides
- Reagents
- Recombinant Proteins
- Ria Kits
- RNA
- Test Kits
The discovery that sclerostin is the faulty protein underlying the uncommon heritable bone mass dysfunction, sclerosteosis, in the end led to growth of anti-sclerostin antibodies as a new therapy for osteoporosis. In the period of giant scale GWAS, many further genetic alerts related to bone mass and associated traits have since been reported. However, how greatest to interrogate these alerts in order to determine the underlying gene chargeable for these genetic associations, a prerequisite for figuring out drug targets for additional remedies, stays a problem.
These databases present details about potential molecular mediators corresponding to mRNA expression, protein expression, and DNA methylation ranges, which might be interrogated to map genetic alerts to particular genes based mostly on identification of causal pathways between the genetic sign and the phenotype being studied. Functional analysis of potential causative genes has been facilitated by characterization of the “osteocyte signature”, by broad phenotyping of knockout mice with deletions of over 7,000 genes, in which extra detailed skeletal phenotyping is presently being undertaken, and by growth of zebrafish as a extremely environment friendly further in vivo mannequin for useful research of the skeleton.
Looking to the future, this increasing repertoire of instruments affords the hope of precisely defining the main genetic alerts which contribute to osteoporosis. This could in flip result in the identification of further therapeutic targets, and in the end new remedies for osteoporosis. The sources obtainable for supporting useful genomics analysis continues to increase, exemplified by “multi-omics” database sources, with improved availability of datasets derived from bone tissues.
On the street to sensible biomaterials for bone analysis: definitions, ideas, advances, and outlook
The demand for biomaterials that promote the restore, substitute, or restoration of exhausting and delicate tissues continues to develop as the inhabitants ages. Traditionally, sensible biomaterials have been thought as people who reply to stimuli. However, the steady evolution of the subject warrants a contemporary take a look at the idea of smartness of biomaterials. This evaluation presents a redefinition of the time period “Smart Biomaterial” and discusses latest advances in and functions of sensible biomaterials for exhausting tissue restoration and regeneration.
To make clear the use of the time period “sensible biomaterials”, we suggest 4 levels of smartness in accordance with the stage of interplay of the biomaterials with the bio-environment and the organic/mobile responses they elicit, defining these supplies as inert, lively, responsive, and autonomous. Then, we current an up-to-date survey of functions of sensible biomaterials for exhausting tissues, based mostly on the supplies’ responses (exterior and inside stimuli) and their use as immune-modulatory biomaterials. Finally, we talk about the limitations and obstacles to the translation from primary analysis (bench) to medical utilization that’s required for the growth of clinically related functions of these applied sciences.
Breast most cancers generally metastasizes to bone, ensuing in osteolytic lesions and poor affected person high quality of life. The bone extracellular matrix (ECM) performs a crucial function in most cancers cell metastasis by means of the bodily and biochemical cues it supplies to help mobile crosstalk. Current two-dimensional in-vitro fashions lack the spatial and biochemical complexities of the native ECM and don’t totally recapitulate crosstalk that happens between the tumor and endogenous stromal cells. Engineered fashions corresponding to bone-on-a-chip, extramedullary bone, and bioreactors are presently used to mannequin mobile crosstalk and bone-tumor cell interactions, however fall quick of offering a bone-biomimetic microenvironment.
Three-dimensional bioprinting permits for the deposition of biocompatible supplies and dwelling cells in complicated architectures, in addition to supplies a means to raised replicate organic tissue niches in-vitro. In most cancers analysis particularly, 3D constructs have been instrumental in seminal work modeling most cancers cell dissemination to bone and bone-tumor cell crosstalk in the skeleton. Furthermore, the use of biocompatible supplies, corresponding to hydroxyapatite, permits for printing of bone-like microenvironments with the skill to be implanted and studied in in-vivo animal fashions. Moreover, the use of bioprinted fashions may drive the growth of novel most cancers therapies and drug supply automobiles.

Horseradish Peroxidase-Crosslinked Calcium-Containing Silk Fibroin Hydrogels as Artificial Matrices for Bone Cancer Research
Hydrogels, being succesful of mimicking the extracellular matrix composition of tissues, are vastly used as synthetic matrices in tissue engineering functions. In this research, the era of horseradish peroxidase (HRP)-crosslinked silk fibroin (SF) hydrogels, utilizing calcium peroxide as oxidizer is reported. The proposed quick forming calcium-containing SF hydrogels spontaneously endure SF conformational adjustments from random coil to β-sheet throughout time, exhibiting ionic, and pH stimuli responsiveness. In vitro response reveals calcium-containing SF hydrogels’ encapsulation properties and their skill to advertise SaOs-2 tumor cells dying after 10 days of culturing, upon full β-sheet conformation transition.
IBSP (Bone Sialoprotein 2, Bone Sialoprotein II, BSP II, Cell-binding Sialoprotein, Integrin-binding Sialoprotein, BNSP) |
|||
| MBS6507722-01mL | MyBiosource | 0.1mL | 660 EUR |
IBSP (Bone Sialoprotein 2, Bone Sialoprotein II, BSP II, Cell-binding Sialoprotein, Integrin-binding Sialoprotein, BNSP) |
|||
| MBS6507722-5x01mL | MyBiosource | 5x0.1mL | 2810 EUR |
IBSP, NT (IBSP, BNSP, Bone sialoprotein 2, Bone sialoprotein II, Cell-binding sialoprotein, Integrin-binding sialoprotein) |
|||
| MBS6012925-02mL | MyBiosource | 0.2(mL | 695 EUR |
IBSP, NT (IBSP, BNSP, Bone sialoprotein 2, Bone sialoprotein II, Cell-binding sialoprotein, Integrin-binding sialoprotein) |
|||
| MBS6012925-5x02mL | MyBiosource | 5x0.2mL | 2975 EUR |
IBSP, NT (IBSP, BNSP, Bone sialoprotein 2, Bone sialoprotein II, Cell-binding sialoprotein, Integrin-binding sialoprotein) (AP) |
|||
| MBS6309035-02mL | MyBiosource | 0.2mL | 980 EUR |
IBSP, NT (IBSP, BNSP, Bone sialoprotein 2, Bone sialoprotein II, Cell-binding sialoprotein, Integrin-binding sialoprotein) (AP) |
|||
| MBS6309035-5x02mL | MyBiosource | 5x0.2mL | 4250 EUR |
IBSP, NT (IBSP, BNSP, Bone sialoprotein 2, Bone sialoprotein II, Cell-binding sialoprotein, Integrin-binding sialoprotein) (APC) |
|||
| MBS6309036-02mL | MyBiosource | 0.2mL | 980 EUR |
IBSP, NT (IBSP, BNSP, Bone sialoprotein 2, Bone sialoprotein II, Cell-binding sialoprotein, Integrin-binding sialoprotein) (APC) |
|||
| MBS6309036-5x02mL | MyBiosource | 5x0.2mL | 4250 EUR |
IBSP, NT (IBSP, BNSP, Bone sialoprotein 2, Bone sialoprotein II, Cell-binding sialoprotein, Integrin-binding sialoprotein) (FITC) |
|||
| MBS6309038-02mL | MyBiosource | 0.2mL | 980 EUR |
IBSP, NT (IBSP, BNSP, Bone sialoprotein 2, Bone sialoprotein II, Cell-binding sialoprotein, Integrin-binding sialoprotein) (FITC) |
|||
| MBS6309038-5x02mL | MyBiosource | 5x0.2mL | 4250 EUR |
IBSP, NT (IBSP, BNSP, Bone sialoprotein 2, Bone sialoprotein II, Cell-binding sialoprotein, Integrin-binding sialoprotein) (PE) |
|||
| MBS6309045-02mL | MyBiosource | 0.2mL | 980 EUR |
IBSP, NT (IBSP, BNSP, Bone sialoprotein 2, Bone sialoprotein II, Cell-binding sialoprotein, Integrin-binding sialoprotein) (PE) |
|||
| MBS6309045-5x02mL | MyBiosource | 5x0.2mL | 4250 EUR |
IBSP, NT (IBSP, BNSP, Bone sialoprotein 2, Bone sialoprotein II, Cell-binding sialoprotein, Integrin-binding sialoprotein) (Biotin) |
|||
| MBS6309037-02mL | MyBiosource | 0.2mL | 980 EUR |
IBSP, NT (IBSP, BNSP, Bone sialoprotein 2, Bone sialoprotein II, Cell-binding sialoprotein, Integrin-binding sialoprotein) (Biotin) |
|||
| MBS6309037-5x02mL | MyBiosource | 5x0.2mL | 4250 EUR |
IBSP, NT (IBSP, BNSP, Bone sialoprotein 2, Bone sialoprotein II, Cell-binding sialoprotein, Integrin-binding sialoprotein) (MaxLight 405) |
|||
| MBS6309040-01mL | MyBiosource | 0.1mL | 980 EUR |
IBSP, NT (IBSP, BNSP, Bone sialoprotein 2, Bone sialoprotein II, Cell-binding sialoprotein, Integrin-binding sialoprotein) (MaxLight 405) |
|||
| MBS6309040-5x01mL | MyBiosource | 5x0.1mL | 4250 EUR |
IBSP, NT (IBSP, BNSP, Bone sialoprotein 2, Bone sialoprotein II, Cell-binding sialoprotein, Integrin-binding sialoprotein) (MaxLight 490) |
|||
| MBS6309041-01mL | MyBiosource | 0.1mL | 980 EUR |
IBSP, NT (IBSP, BNSP, Bone sialoprotein 2, Bone sialoprotein II, Cell-binding sialoprotein, Integrin-binding sialoprotein) (MaxLight 490) |
|||
| MBS6309041-5x01mL | MyBiosource | 5x0.1mL | 4250 EUR |
IBSP, NT (IBSP, BNSP, Bone sialoprotein 2, Bone sialoprotein II, Cell-binding sialoprotein, Integrin-binding sialoprotein) (MaxLight 550) |
|||
| MBS6309042-01mL | MyBiosource | 0.1mL | 980 EUR |
IBSP, NT (IBSP, BNSP, Bone sialoprotein 2, Bone sialoprotein II, Cell-binding sialoprotein, Integrin-binding sialoprotein) (MaxLight 550) |
|||
| MBS6309042-5x01mL | MyBiosource | 5x0.1mL | 4250 EUR |
IBSP, NT (IBSP, BNSP, Bone sialoprotein 2, Bone sialoprotein II, Cell-binding sialoprotein, Integrin-binding sialoprotein) (MaxLight 650) |
|||
| MBS6309043-01mL | MyBiosource | 0.1mL | 980 EUR |
IBSP, NT (IBSP, BNSP, Bone sialoprotein 2, Bone sialoprotein II, Cell-binding sialoprotein, Integrin-binding sialoprotein) (MaxLight 650) |
|||
| MBS6309043-5x01mL | MyBiosource | 5x0.1mL | 4250 EUR |
IBSP, NT (IBSP, BNSP, Bone sialoprotein 2, Bone sialoprotein II, Cell-binding sialoprotein, Integrin-binding sialoprotein) (MaxLight 750) |
|||
| MBS6309044-01mL | MyBiosource | 0.1mL | 980 EUR |
IBSP, NT (IBSP, BNSP, Bone sialoprotein 2, Bone sialoprotein II, Cell-binding sialoprotein, Integrin-binding sialoprotein) (MaxLight 750) |
|||
| MBS6309044-5x01mL | MyBiosource | 5x0.1mL | 4250 EUR |
IBSP, NT (IBSP, BNSP, Bone sialoprotein 2, Bone sialoprotein II, Cell-binding sialoprotein, Integrin-binding sialoprotein) (Azide free) (HRP) |
|||
| MBS6309039-02mL | MyBiosource | 0.2mL | 980 EUR |
IBSP, NT (IBSP, BNSP, Bone sialoprotein 2, Bone sialoprotein II, Cell-binding sialoprotein, Integrin-binding sialoprotein) (Azide free) (HRP) |
|||
| MBS6309039-5x02mL | MyBiosource | 5x0.2mL | 4250 EUR |
Sialoprotein, Bone (BSP, Bone Sialoprotein 2, BSP2, Cell-binding Sialoprotein, Integrin-binding Sialoprotein) |
|||
| MBS630383-002mL | MyBiosource | 0.02mL | 455 EUR |
Sialoprotein, Bone (BSP, Bone Sialoprotein 2, BSP2, Cell-binding Sialoprotein, Integrin-binding Sialoprotein) |
|||
| MBS630383-01mL | MyBiosource | 0.1mL | 965 EUR |
Sialoprotein, Bone (BSP, Bone Sialoprotein 2, BSP2, Cell-binding Sialoprotein, Integrin-binding Sialoprotein) |
|||
| MBS630383-5x01mL | MyBiosource | 5x0.1mL | 4185 EUR |
Sialoprotein, Bone (BSP, Bone Sialoprotein 2, BSP2, Cell-binding Sialoprotein, Integrin-binding Sialoprotein) |
|||
| MBS625086-001mg | MyBiosource | 0.01mg | 450 EUR |
Sialoprotein, Bone (BSP, Bone Sialoprotein 2, BSP2, Cell-binding Sialoprotein, Integrin-binding Sialoprotein) |
|||
| MBS625086-01mg | MyBiosource | 0.1mg | 885 EUR |
Sialoprotein, Bone (BSP, Bone Sialoprotein 2, BSP2, Cell-binding Sialoprotein, Integrin-binding Sialoprotein) |
|||
| MBS625086-5x01mg | MyBiosource | 5x0.1mg | 3830 EUR |
Sialoprotein, Bone (BSP, Bone Sialoprotein 2, BSP2, Cell-binding Sialoprotein, Integrin-binding Sialoprotein) |
|||
| MBS626609-002mL | MyBiosource | 0.02mL | 430 EUR |
Sialoprotein, Bone (BSP, Bone Sialoprotein 2, BSP2, Cell-binding Sialoprotein, Integrin-binding Sialoprotein) |
|||
| MBS626609-01mL | MyBiosource | 0.1mL | 805 EUR |
Sialoprotein, Bone (BSP, Bone Sialoprotein 2, BSP2, Cell-binding Sialoprotein, Integrin-binding Sialoprotein) |
|||
| MBS626609-5x01mL | MyBiosource | 5x0.1mL | 3485 EUR |
Sialoprotein, Bone (BSP, Bone Sialoprotein 2, BSP2, Cell-binding Sialoprotein, Integrin-binding Sialoprotein) |
|||
| MBS609998-001mg | MyBiosource | 0.01mg | 435 EUR |
Sialoprotein, Bone (BSP, Bone Sialoprotein 2, BSP2, Cell-binding Sialoprotein, Integrin-binding Sialoprotein) |
|||
| MBS609998-01mg | MyBiosource | 0.1mg | 990 EUR |
Sialoprotein, Bone (BSP, Bone Sialoprotein 2, BSP2, Cell-binding Sialoprotein, Integrin-binding Sialoprotein) |
|||
| MBS609998-5x01mg | MyBiosource | 5x0.1mg | 4305 EUR |
Sialoprotein, Bone, aa294-295 (BSP, Bone Sialoprotein 2, BSP2, Cell-binding Sialoprotein, Integrin-binding Sialoprotein) |
|||
| MBS629727-002mL | MyBiosource | 0.02mL | 455 EUR |
Sialoprotein, Bone, aa294-295 (BSP, Bone Sialoprotein 2, BSP2, Cell-binding Sialoprotein, Integrin-binding Sialoprotein) |
|||
| MBS629727-01mL | MyBiosource | 0.1mL | 965 EUR |
Sialoprotein, Bone, aa294-295 (BSP, Bone Sialoprotein 2, BSP2, Cell-binding Sialoprotein, Integrin-binding Sialoprotein) |
|||
| MBS629727-5x01mL | MyBiosource | 5x0.1mL | 4185 EUR |
Sialoprotein, Bone, aa262-279 (BSP, Bone Sialoprotein 2, BSP2, Cell-binding Sialoprotein, Integrin-binding Sialoprotein) |
|||
| MBS627011-002mL | MyBiosource | 0.02mL | 455 EUR |
Sialoprotein, Bone, aa262-279 (BSP, Bone Sialoprotein 2, BSP2, Cell-binding Sialoprotein, Integrin-binding Sialoprotein) |
|||
| MBS627011-01mL | MyBiosource | 0.1mL | 965 EUR |
Sialoprotein, Bone, aa262-279 (BSP, Bone Sialoprotein 2, BSP2, Cell-binding Sialoprotein, Integrin-binding Sialoprotein) |
|||
| MBS627011-5x01mL | MyBiosource | 5x0.1mL | 4185 EUR |
Sialoprotein, Bone, aa108-122 (BSP, Bone Sialoprotein 2, BSP2, Cell-binding Sialoprotein, Integrin-binding Sialoprotein) |
|||
| MBS631265-002mL | MyBiosource | 0.02mL | 455 EUR |
Sialoprotein, Bone, aa108-122 (BSP, Bone Sialoprotein 2, BSP2, Cell-binding Sialoprotein, Integrin-binding Sialoprotein) |
|||
| MBS631265-01mL | MyBiosource | 0.1mL | 965 EUR |
Sialoprotein, Bone, aa108-122 (BSP, Bone Sialoprotein 2, BSP2, Cell-binding Sialoprotein, Integrin-binding Sialoprotein) |
|||
| MBS631265-5x01mL | MyBiosource | 5x0.1mL | 4185 EUR |
Sialoprotein, Bone, aa39-47 (BSP, Bone Sialoprotein 2, BSP2, Cell-binding Sialoprotein, Integrin-binding Sialoprotein) |
|||
| MBS629374-002mL | MyBiosource | 0.02mL | 455 EUR |
Sialoprotein, Bone, aa39-47 (BSP, Bone Sialoprotein 2, BSP2, Cell-binding Sialoprotein, Integrin-binding Sialoprotein) |
|||
| MBS629374-01mL | MyBiosource | 0.1mL | 965 EUR |
Sialoprotein, Bone, aa39-47 (BSP, Bone Sialoprotein 2, BSP2, Cell-binding Sialoprotein, Integrin-binding Sialoprotein) |
|||
| MBS629374-5x01mL | MyBiosource | 5x0.1mL | 4185 EUR |
Sialoprotein, Bone, aa201-211 (BSP, Bone Sialoprotein 2, BSP2, Cell-binding Sialoprotein, Integrin-binding Sialoprotein) |
|||
| MBS629885-002mL | MyBiosource | 0.02mL | 455 EUR |
Sialoprotein, Bone, aa201-211 (BSP, Bone Sialoprotein 2, BSP2, Cell-binding Sialoprotein, Integrin-binding Sialoprotein) |
|||
| MBS629885-01mL | MyBiosource | 0.1mL | 965 EUR |
Sialoprotein, Bone, aa201-211 (BSP, Bone Sialoprotein 2, BSP2, Cell-binding Sialoprotein, Integrin-binding Sialoprotein) |
|||
| MBS629885-5x01mL | MyBiosource | 5x0.1mL | 4185 EUR |
Bone Sialoprotein |
|||
| E8ER1904-28 | EnoGene | 100ul | 275 EUR |
|
Description: Available in various conjugation types. |
|||
Bone Sialoprotein |
|||
| MBS8577124-01mL | MyBiosource | 0.1mL | 345 EUR |
Bone Sialoprotein |
|||
| MBS8577124-01mLAF405L | MyBiosource | 0.1mL(AF405L) | 565 EUR |
Bone Sialoprotein |
|||
| MBS8577124-01mLAF405S | MyBiosource | 0.1mL(AF405S) | 565 EUR |
Bone Sialoprotein |
|||
| MBS8577124-01mLAF610 | MyBiosource | 0.1mL(AF610) | 565 EUR |
Bone Sialoprotein |
|||
| MBS8577124-01mLAF635 | MyBiosource | 0.1mL(AF635) | 565 EUR |
Bone Sialoprotein |
|||
| PC-065 | Kamiya Biomedical Company | Polyclonal | Ask for price |
Bone sialoprotein 2 |
|||
| AP78800 | SAB | 1mg | 2640 EUR |
Bone sialoprotein 2 |
|||
| AP87806 | SAB | 1mg | 2640 EUR |
Bone sialoprotein 2 |
|||
| AP87916 | SAB | 1mg | 2640 EUR |
Bone sialoprotein 2 |
|||
| AP87966 | SAB | 1mg | 2640 EUR |
Bone sialoprotein 2 |
|||
| AP88388 | SAB | 1mg | 2640 EUR |
Bone sialoprotein 2 |
|||
| AP89478 | SAB | 1mg | 2640 EUR |
Bone Sialoprotein Antibody |
|||
| 45125-100ul | SAB | 100ul | 302.4 EUR |
Bone Sialoprotein Antibody |
|||
| 45125-50ul | SAB | 50ul | 224.4 EUR |
Bone Sialoprotein Antibody |
|||
| ABD7738 | Lifescience Market | 100 ug | 525.6 EUR |
Bone Sialoprotein Antibody |
|||
| DF7738 | Affbiotech | 200ul | 420 EUR |
Bone Sialoprotein Antibody |
|||
| DF7738-100ul | Affinity Biosciences | 100ul | 168 EUR |
|
Description: WB,IHC,IF/ICC,ELISA(peptide) |
|||
Bone Sialoprotein Antibody |
|||
| DF7738-200ul | Affinity Biosciences | 200ul | 210 EUR |
|
Description: WB,IHC,IF/ICC,ELISA(peptide) |
|||
Bone Sialoprotein Antibody |
|||
| E19-7738-1 | EnoGene | 50ug/50ul | 145 EUR |
|
Description: Available in various conjugation types. |
|||
Bone Sialoprotein Antibody |
|||
| E19-7738-2 | EnoGene | 100ug/100ul | 225 EUR |
|
Description: Available in various conjugation types. |
|||
Bone Sialoprotein Antibody |
|||
| MBS9608317-01mL | MyBiosource | 0.1mL | 260 EUR |
Bone Sialoprotein Antibody |
|||
| MBS9608317-02mL | MyBiosource | 0.2mL | 305 EUR |
Bone Sialoprotein Antibody |
|||
| MBS9608317-5x02mL | MyBiosource | 5x0.2mL | 1220 EUR |
Bone Sialoprotein Antibody |
|||
| MBS8517114-005mg | MyBiosource | 0.05mg | 235 EUR |
Bone Sialoprotein Antibody |
|||
| MBS8517114-01mg | MyBiosource | 0.1mg | 305 EUR |
Bone Sialoprotein Antibody |
|||
| MBS8517114-01mLAF405M | MyBiosource | 0.1mL(AF405M) | 465 EUR |
Bone Sialoprotein Antibody |
|||
| MBS8517114-01mLAF546 | MyBiosource | 0.1mL(AF546) | 465 EUR |
Bone Sialoprotein Antibody |
|||
| MBS8517114-01mLAF750 | MyBiosource | 0.1mL(AF750) | 465 EUR |
Bone Sialoprotein Antibody |
|||
| ASA-B0239 | Novatein Biosciences, Inc. | 1 Each | Ask for price |
Bone Sialoprotein Antibody |
|||
| ASA-B0240 | Novatein Biosciences, Inc. | 1 Each | Ask for price |
Sialoprotein, Bone (BSP) |
|||
| MBS630597-01mL | MyBiosource | 0.1mL | 790 EUR |
Sialoprotein, Bone (BSP) |
|||
| MBS630597-5x01mL | MyBiosource | 5x0.1mL | 3405 EUR |
Sialoprotein, Bone (BSP) |
|||
| MBS631115-002mL | MyBiosource | 0.02mL | 660 EUR |
Sialoprotein, Bone (BSP) |
|||
| MBS631115-5x002mL | MyBiosource | 5x0.02mL | 2810 EUR |
Sialoprotein, Bone (BSP) |
|||
| MBS628463-002mL | MyBiosource | 0.02mL | 555 EUR |
Sialoprotein, Bone (BSP) |
|||
| MBS628463-01mL | MyBiosource | 0.1mL | 1180 EUR |
Sialoprotein, Bone (BSP) |
|||
| MBS628463-5x01mL | MyBiosource | 5x0.1mL | 5150 EUR |
Sialoprotein, Bone (BSP) |
|||
| MBS625963-002mL | MyBiosource | 0.02mL | 640 EUR |
Sialoprotein, Bone (BSP) |
|||
| MBS625963-5x002mL | MyBiosource | 5x0.02mL | 2740 EUR |
Sialoprotein, Bone, Carbohydrate Deficient (Carbohydrate Deficient Bone Sialoprotein, CD-BSP) |
|||
| MBS608598-001mg | MyBiosource | 0.01mg | 505 EUR |
Sialoprotein, Bone, Carbohydrate Deficient (Carbohydrate Deficient Bone Sialoprotein, CD-BSP) |
|||
| MBS608598-01mg | MyBiosource | 0.1mg | 990 EUR |
Sialoprotein, Bone, Carbohydrate Deficient (Carbohydrate Deficient Bone Sialoprotein, CD-BSP) |
|||
| MBS608598-5x01mg | MyBiosource | 5x0.1mg | 4305 EUR |
Active Bone Sialoprotein (BSP) |
|||
| APB092Hu61 | Cloud-Clone | 10ug | 301 EUR |
Bone sialoprotein Rabbit pAb |
|||
| E47R2668 | EnoGene | 100ul | 295 EUR |
Bone Sialoprotein (BSP) Antibody |
|||
| abx175605-1096tests | Abbexa | 10 × 96 tests | Ask for price |
Bone Sialoprotein (BSP) Antibody |
|||
| 20-abx175605 | Abbexa |
|
|
Bone Sialoprotein (BSP) Antibody |
|||
| abx175605-596tests | Abbexa | 5 × 96 tests | Ask for price |
Bone Sialoprotein (BSP) Antibody |
|||
| abx175605-96tests | Abbexa | 96 tests | 712.5 EUR |
Bone Sialoprotein (BSP) Antibody |
|||
| abx175606-1096tests | Abbexa | 10 × 96 tests | 725 EUR |
Bone Sialoprotein (BSP) Antibody |
|||
| 20-abx175606 | Abbexa |
|
|
Bone Sialoprotein (BSP) Antibody |
|||
| abx175606-596tests | Abbexa | 5 × 96 tests | 337.5 EUR |
Bone Sialoprotein (BSP) Antibody |
|||
| abx175606-96tests | Abbexa | 96 tests | 262.5 EUR |
Bone Sialoprotein (BSP) Antibody |
|||
| 20-abx175607 | Abbexa |
|
|
Bone Sialoprotein (BSP) Antibody |
|||
| 20-abx171455 | Abbexa |
|
|
Bone Sialoprotein (BSP) Antibody |
|||
| abx171455-1ml | Abbexa | 1 ml | 750 EUR |
Bone Sialoprotein (IBSP) Antibody |
|||
| 20-abx216122 | Abbexa |
|
|
Eukaryotic Bone Sialoprotein (BSP) |
|||
| EPB092Hu61 | Cloud-Clone | 10ug | 261 EUR |
Eukaryotic Bone Sialoprotein (BSP) |
|||
| EPB092Hu62 | Cloud-Clone | 10ug | 263 EUR |
Eukaryotic Bone Sialoprotein (BSP) |
|||
| EPB092Mu61 | Cloud-Clone | 10ug | 210 EUR |
Eukaryotic Bone Sialoprotein (BSP) |
|||
| MBS2122461-001mg | MyBiosource | 0.01mg | 215 EUR |
Eukaryotic Bone Sialoprotein (BSP) |
|||
| MBS2122461-005mg | MyBiosource | 0.05mg | 430 EUR |
Eukaryotic Bone Sialoprotein (BSP) |
|||
| MBS2122461-01mg | MyBiosource | 0.1mg | 655 EUR |
Eukaryotic Bone Sialoprotein (BSP) |
|||
| MBS2122461-02mg | MyBiosource | 0.2mg | 805 EUR |
Eukaryotic Bone Sialoprotein (BSP) |
|||
| MBS2122461-05mg | MyBiosource | 0.5mg | 1555 EUR |
Eukaryotic Bone Sialoprotein (BSP) |
|||
| MBS2122462-001mg | MyBiosource | 0.01mg | 190 EUR |
Eukaryotic Bone Sialoprotein (BSP) |
|||
| MBS2122462-005mg | MyBiosource | 0.05mg | 355 EUR |
Eukaryotic Bone Sialoprotein (BSP) |
|||
| MBS2122462-01mg | MyBiosource | 0.1mg | 540 EUR |
Eukaryotic Bone Sialoprotein (BSP) |
|||
| MBS2122462-02mg | MyBiosource | 0.2mg | 660 EUR |
Eukaryotic Bone Sialoprotein (BSP) |
|||
| MBS2122462-05mg | MyBiosource | 0.5mg | 1260 EUR |
Eukaryotic Bone Sialoprotein (BSP) |
|||
| MBS2124303-001mg | MyBiosource | 0.01mg | 220 EUR |
Eukaryotic Bone Sialoprotein (BSP) |
|||
| MBS2124303-005mg | MyBiosource | 0.05mg | 435 EUR |
Eukaryotic Bone Sialoprotein (BSP) |
|||
| MBS2124303-01mg | MyBiosource | 0.1mg | 660 EUR |
Eukaryotic Bone Sialoprotein (BSP) |
|||
| MBS2124303-02mg | MyBiosource | 0.2mg | 810 EUR |
Eukaryotic Bone Sialoprotein (BSP) |
|||
| MBS2124303-05mg | MyBiosource | 0.5mg | 1570 EUR |
Eukaryotic Bone Sialoprotein (BSP) |
|||
| RPU58873-100ug | Biomatik Corporation | 100ug | 705.6 EUR |
Eukaryotic Bone Sialoprotein (BSP) |
|||
| RPU58873-1mg | Biomatik Corporation | 1mg | 3276 EUR |
Eukaryotic Bone Sialoprotein (BSP) |
|||
| RPU58873-50ug | Biomatik Corporation | 50ug | 519.8 EUR |
Eukaryotic Bone Sialoprotein (BSP) |
|||
| RPU59089-100ug | Biomatik Corporation | 100ug | 975.2 EUR |
Eukaryotic Bone Sialoprotein (BSP) |
|||
| RPU59089-1mg | Biomatik Corporation | 1mg | 3814.2 EUR |
Eukaryotic Bone Sialoprotein (BSP) |
|||
| RPU59089-50ug | Biomatik Corporation | 50ug | 609.6 EUR |
Eukaryotic Bone Sialoprotein (BSP) |
|||
| RPU59090-100ug | Biomatik Corporation | 100ug | 982.7 EUR |
Eukaryotic Bone Sialoprotein (BSP) |
|||
| RPU59090-1mg | Biomatik Corporation | 1mg | 3843.5 EUR |
Eukaryotic Bone Sialoprotein (BSP) |
|||
| RPU59090-50ug | Biomatik Corporation | 50ug | 614.3 EUR |
Recombinant Bone Sialoprotein (BSP) |
|||
| MBS2139931-001mg | MyBiosource | 0.01mg | 155 EUR |
Recombinant Bone Sialoprotein (BSP) |
|||
| MBS2139931-005mg | MyBiosource | 0.05mg | 260 EUR |
Recombinant Bone Sialoprotein (BSP) |
|||
| MBS2139931-01mg | MyBiosource | 0.1mg | 375 EUR |
Recombinant Bone Sialoprotein (BSP) |
|||
| MBS2139931-02mg | MyBiosource | 0.2mg | 460 EUR |
Recombinant Bone Sialoprotein (BSP) |
|||
| MBS2139931-05mg | MyBiosource | 0.5mg | 860 EUR |
Recombinant Bone Sialoprotein (BSP) |
|||
| MBS2097632-001mg | MyBiosource | 0.01mg | 175 EUR |
Calcium-containing SF hydrogels’ angiogenic potential investigated in an in ovo chick chorioallantoic membrane (CAM) assay, present a excessive quantity of converging blood vessels as in comparison with the unfavorable management, though no endothelial cells infiltration is noticed. The in vivo response evaluated in subcutaneous implantation in CD1 and nude NCD1 mice reveals that calcium-containing SF hydrogels are steady as much as 6 weeks after implantation. However, an elevated quantity of lifeless cells are additionally current in the surrounding tissue. The outcomes recommend the potential of calcium-containing SF hydrogels for use as novel in situ therapeutics for bone most cancers therapy functions, significantly to osteosarcoma.
